Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) Non Operating Income (2024 - 2025)

Beta Bionics (BBNX) has disclosed Non Operating Income for 2 consecutive years, with -$1.5 million as the latest value for Q4 2025.

  • Quarterly Non Operating Income rose 84.03% to -$1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.5 million through Dec 2025, up 84.02% year-over-year, with the annual reading at -$1.5 million for FY2025, 84.02% up from the prior year.
  • Non Operating Income hit -$1.5 million in Q4 2025 for Beta Bionics, down from $1000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $4000.0 in Q1 2024 to a low of -$9.5 million in Q4 2024.